Loading…
Profusa, Inc. is projected to rise to $0.432 by 2027, a +17% move from its current price of $0.3705. PFSA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.3458 | $0.3702 | $0.3964 | -0.07% |
| May 30 | $0.3359 | $0.37 | $0.4075 | -0.14% |
| May 31 | $0.3285 | $0.3697 | $0.4162 | -0.21% |
| Jun 1 | $0.3223 | $0.3695 | $0.4236 | -0.28% |
| Jun 2 | $0.3169 | $0.3692 | $0.4302 | -0.34% |
| Jun 3 | $0.3121 | $0.369 | $0.4362 | -0.41% |
| Jun 4 | $0.3077 | $0.3687 | $0.4418 | -0.48% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3077 | $0.3687 | $0.4418 | -0.48% |
| Week 2 | $0.2841 | $0.3669 | $0.4739 | -0.96% |
| Week 3 | $0.267 | $0.3652 | $0.4995 | -1.44% |
| Week 4 | $0.2531 | $0.3634 | $0.5217 | -1.91% |
| Week 5 | $0.2414 | $0.3617 | $0.5419 | -2.38% |
| Week 6 | $0.2311 | $0.3599 | $0.5605 | -2.85% |
| Week 7 | $0.222 | $0.3582 | $0.5779 | -3.32% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Profusa, Inc. is a digital health technology company operating in the Healthcare sector. It develops bioengineered sensors to detect and continuously transmit clinical-grade data for personal and medical use in the United States.
The company is based in Berkeley, California, and offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. It researches the Lumee Glucose Platform designed to monitor glucose levels in interstitial fluid.
The profile here centers on Profusa as a listed entity with operations focused on sensor-based health monitoring and related platforms that combine biosensing with data transmission for clinical use in the U.S.
Profusa, Inc. (PFSA) is currently trading with a price of $0.3762 and a market capitalization of $1.66M. It is ranked 5496 by market cap. The stock sits in the Healthcare sector and is associated with a set of forecasted price paths through 2050 that show predominantly bullish momentum in later years.
The current price and market position are complemented by a long-range forecast that begins near the current price in 2026 and projects meaningful upside by 2030 and beyond, culminating in a 2050 avg price of $1.21 with a 222.1% ROI. These figures imply a gradual uptrend over the multi-year horizon, with near-term neutral signals and increasingly bullish prospects in the later years.
In the near term, the 30-day technical picture and the multi-year forecast align to produce a cautious-to-positive outlook. The stock trades at a modest level in the context of a small market cap, with a price path that the forecast associates with rising averages and notable upside potential by 2030 and later.
A major floor 58.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.7% away) — a key level to hold.
The nearest ceiling, 86.8% above — a clean break opens room to run.
A major ceiling 2227.9% above — clearing it would confirm fresh momentum.
Key PFSA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PFSA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.3786 | Sell | $0.3815 | Sell |
| MA 10 | $0.4039 | Sell | $0.4066 | Sell |
| MA 20 | $0.4616 | Sell | $0.4672 | Sell |
| MA 50 | $0.6129 | Sell | $1.07 | Sell |
| MA 100 | $2.44 | Sell | $5.76 | Sell |
| MA 200 | $11.59 | Sell | $27.82 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 33.53 | Neutral |
| Stoch RSI (14) | 9.29 | Buy |
| CCI (20) | -101.89 | Sell |
| Williams %R (14) | -97.97 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -28.10 | Sell |
| Bollinger %B (20,2) | 0.17 | Neutral |
| Stochastic %K (14) | 2.03 | Buy |
| TRIX (15) | -2.20 | Sell |
| Awesome (5,34) | -0.17 | Sell |
| Ultimate (7,14,28) | 18.45 | Buy |
| Momentum (10) | -0.08 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 0.36 | Buy |
| ADX (14) | 28.34 | Sell |
| ATR (14) | 0.04 | Info |
The 30-day technical picture is neutral, with RSI(14) at 30. The 50-day simple moving average sits at $0.634 and the 200-day simple moving average at $11.94, highlighting a wide gap between shorter- and longer-term trends.
Support is listed at $0.37 and resistance at $0.725, framing a near-term trading range around the current price. The 30-day range spans from $0.2337 to $0.6055, underscoring limited upside momentum in the immediate horizon alongside cautious downside risk.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.368 | $0.3705 | $0.4711 | 0% | Neutral | |
| $0.2851 | $0.432 | $0.7085 | +17% | Neutral | |
| $0.2939 | $0.4883 | $0.8657 | +32% | Bullish | |
| $0.2782 | $0.5016 | $0.9435 | +35% | Bullish | |
| $0.2943 | $0.5732 | $1.13 | +55% | Bullish | |
| $0.2147 | $0.4506 | $0.928 | +22% | Bullish | |
| $0.1775 | $0.3945 | $0.8428 | +6% | Neutral | |
| $0.2139 | $0.4753 | $1.05 | +28% | Bullish | |
| $0.2505 | $0.5566 | $1.27 | +50% | Bullish | |
| $0.3136 | $0.6968 | $1.60 | +88% | Bullish | |
| $0.287 | $0.6378 | $1.47 | +72% | Bullish | |
| $0.5309 | $1.18 | $2.71 | +218% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.368 | $0.3705 | $0.4446 | +0.00% |
| June 2026 | $0.3093 | $0.3775 | $0.4815 | +1.88% |
| July 2026 | $0.2783 | $0.3479 | $0.4593 | -7.83% |
| August 2026 | $0.246 | $0.3134 | $0.4246 | -9.91% |
| September 2026 | $0.2534 | $0.328 | $0.4537 | +4.66% |
| October 2026 | $0.2624 | $0.3448 | $0.4858 | +5.11% |
| November 2026 | $0.2443 | $0.3253 | $0.4657 | -5.66% |
| December 2026 | $0.2403 | $0.3241 | $0.4711 | -0.36% |
Click any year to see its month-by-month PFSA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, PFSA could reach as high as $0.4711, with a base case around $0.3705 and support toward $0.368 — roughly 0% from $0.3705. A consolidation phase looks the most probable path here.
Expect PFSA to range from $0.2851 to $0.7085 through 2027. The $0.432 average target implies a +17% move from current prices. That is up +17% on the projected 2026 average. Price action looks broadly range-bound.
The PFSA price prediction for 2028 points to an average of $0.4883 (low $0.2939, high $0.8657) — a potential gain of +32% on today's $0.3705. Buyers look set to stay in control over this stretch.
In 2029, PFSA is projected to trade between $0.2782 and $0.9435, averaging $0.5016 — a potential gain of +35% from today's $0.3705. That is up +3% on the projected 2028 average. Momentum favours further upside here.
Profusa, Inc.'s 2030 outlook centres on $0.5732, within a $0.2943 to $1.13 range. That is up +14% on the projected 2029 average. That marks a +55% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, PFSA could reach as high as $0.928, with a base case around $0.4506 and support toward $0.2147 — roughly +22% from $0.3705. Momentum favours further upside here.
Expect PFSA to range from $0.1775 to $0.8428 through 2032. The $0.3945 average target implies a +6% move from current prices. That is -12% versus the projected 2031 average. A consolidation phase looks the most probable path here.
The PFSA price prediction for 2033 points to an average of $0.4753 (low $0.2139, high $1.05) — a potential gain of +28% on today's $0.3705. Momentum favours further upside here.
In 2034, PFSA is projected to trade between $0.2505 and $1.27, averaging $0.5566 — a potential gain of +50% from today's $0.3705. That is up +17% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Profusa, Inc.'s 2035 outlook centres on $0.6968, within a $0.3136 to $1.60 range. That is up +25% on the projected 2034 average. That marks a +88% change versus current levels. Momentum favours further upside here.
By 2040, PFSA could reach as high as $1.47, with a base case around $0.6378 and support toward $0.287 — roughly +72% from $0.3705. Buyers look set to stay in control over this stretch.
Expect PFSA to range from $0.5309 to $2.71 through 2050. The $1.18 average target implies a +218% move from current prices. That is up +85% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in PFSA today (≈ 2,699.055331 PFSA) could be worth
$3,184
+$2,184 (+218%) by 2050 · US Dollar
Based on the average projected PFSA price of $1.18 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PFSAwould be worth at today's price.
$1,000 invested in PFSA on Jul 11, 2025 (≈ 5.333333 PFSA) would be worth
$1.98
-$998.02 (-99.8%) today · 0.00× · US Dollar
Based on a PFSA entry price of $187.5 vs. today's $0.3705.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.408 | $908.09 | -9.2% |
| 1 month ago | $0.513 | $722.22 | -27.8% |
| 3 months ago | $1.22 | $303.69 | -69.6% |
| 6 months ago | $12.68 | $29.23 | -97.1% |
| All time ago | $187.5 | $1.98 | -99.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PFSA forecast.
Our base-case forecast reaches $0.74 around 2050.
Implied market cap at $0.74: $3.45M
The multi-year forecast shows a progression from a neutral stance in the near term to increasingly bullish momentum in the longer term. Key milestones include a 2030 average price of $0.5832 with a 55% ROI, a 2040 average of $0.6398 with a 70.1% ROI, and a 2050 average of $1.21 with a 222.1% ROI. These figures reflect a path of rising averages and expanding upside potential across the late 2020s into the 2040s and 2050.
Earlier years in the forecast show a mix of neutral and bullish sentiment, with notable gains by 2028 (average $0.4929, ROI 31%) and 2029 (average $0.5143, ROI 36.7%). The trajectory suggests meaningful upside over the long horizon, but the accompanying sentiments remain variable; these are estimates and not guarantees, with risk inherent in volatile, thinly traded securities.
Overall, the forecast envisions a bullish longer-term arc for Profusa, driven by rising average prices and substantial ROIs by 2050, while recognizing that near-term performance may remain subdued and subject to market conditions.
Tap a question to reveal the answer.
In 2030, the forecast lists min $0.2983, avg $0.5832, max $1.15, ROI 55%, sentiment BULLISH.
The forecast shows a path toward higher averages and several bullish years (e.g., 2028–2035 and 2040–2050), with 2030 avg $0.5832 (ROI 55%), 2040 avg $0.6398 (ROI 70.1%), and 2050 avg $1.21 (ROI 222.1%). These are estimates and not guarantees.
The 2050 max forecast is $2.79, indicating that a reach above $2 is possible within the horizon, with a max of $2.79.
Current price is $0.3762 and market capitalization is $1.66M.
RSI(14) is 30, sentiment NEUTRAL. SMA(50) is $0.634 and SMA(200) is $11.94. Support is at $0.37 and resistance at $0.725. The 30-day range is $0.2337 to $0.6055.
Profusa, Inc. Community Discussion
0Share your Profusa, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.